INM: SEC Form 425 filed by InMed Pharmaceuticals Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for INM
Across the 5 sessions after earlier INM headlines, the stock closed higher 3 times and lower 1 times, with a median move of 4.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | INM | SPY |
|---|---|---|---|
| Jul 22, 2026 | Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline | +7.8% | -0.1% |
| Jun 5, 2026 | InMed Pharmaceuticals Regains Compliance with Nasdaq Continued Listing Requirements | +1.3% | -2.6% |
| May 19, 2026 | /C O R R E C T I O N -- InMed Pharmaceuticals/and 1 other headline that session | +135.1% | -0.7% |
| Apr 28, 2026 | InMed Pharmaceuticals Amends Preferred Investment Options | -4.3% | -0.5% |
| Dec 9, 2025 | Life Sciences Virtual Investor Forum Agenda Announced for December 11th | +0.0% | -0.1% |
Quantisnow market dataNASDAQ
INM
InMed Pharmaceuticals Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for INM
Full INM profile on Quantisnow Follow INM and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time